Пантетин (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Пантетин" in Russian language version.

refsWebsite

Global rank Russian rank

6nih.gov

4^th place

6^th place

5doi.org

2^nd place

3^rd place

1archive.org

6^th place

9^th place

archive.org

"Treatment of hyperlipoproteinemia with pantethine: a review and analysis of efficacy and tolerability". Nutrition Research. 25 (4): 319—33. April 2005. doi:10.1016/j.nutres.2004.12.009.

doi.org

"Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study". Journal of Clinical Lipidology. 9 (5): 692—7. 2015. doi:10.1016/j.jacl.2015.07.003. PMID 26350816.
"Treatment of hyperlipoproteinemia with pantethine: a review and analysis of efficacy and tolerability". Nutrition Research. 25 (4): 319—33. April 2005. doi:10.1016/j.nutres.2004.12.009.
"Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation". Nutrition Research. 31 (8): 608—15. August 2011. doi:10.1016/j.nutres.2011.08.001. PMID 21925346.
"Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation". Vascular Health and Risk Management. 10: 89—100. 2014. doi:10.2147/VHRM.S57116. PMID 24600231.{{cite journal}}: Википедия:Обслуживание CS1 (не помеченный открытым DOI) (ссылка)
McCarty MF (2001). "Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine". Medical Hypotheses. 56 (3): 314—317. doi:10.1054/mehy.2000.1155. PMID 11359352.

nih.gov

pubmed.ncbi.nlm.nih.gov

"Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study". Journal of Clinical Lipidology. 9 (5): 692—7. 2015. doi:10.1016/j.jacl.2015.07.003. PMID 26350816.
"Pantethine. Monograph". Altern Med Rev. 15 (3): 279—82. September 2010. PMID 21155629.
"Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation". Nutrition Research. 31 (8): 608—15. August 2011. doi:10.1016/j.nutres.2011.08.001. PMID 21925346.
"Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation". Vascular Health and Risk Management. 10: 89—100. 2014. doi:10.2147/VHRM.S57116. PMID 24600231.{{cite journal}}: Википедия:Обслуживание CS1 (не помеченный открытым DOI) (ссылка)
McCarty MF (2001). "Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine". Medical Hypotheses. 56 (3): 314—317. doi:10.1054/mehy.2000.1155. PMID 11359352.
"Pantethine. Monograph". Altern Med Rev. 15 (3): 279—82. September 2010. PMID 21155629.«Pantethine. Monograph». Altern Med Rev. 15 (3): 279-82. September 2010. PMID 21155629.